| 000 | 01659 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513025829.0 | ||
| 264 | 0 | _c19951212 | |
| 008 | 199512s 0 0 eng d | ||
| 022 | _a0300-9475 | ||
| 024 | 7 |
_a10.1111/j.1365-3083.1995.tb03693.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaha, B | |
| 245 | 0 | 0 |
_aImmunobiological studies on experimental visceral leishmaniasis. IV. Kinetics of evolution of disease-promoting versus host-protective cells of monocyte-macrophage lineage and their characterization. _h[electronic resource] |
| 260 |
_bScandinavian journal of immunology _cNov 1995 |
||
| 300 |
_a540-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigen-Presenting Cells _ximmunology |
| 650 | 0 | 4 | _aCell Separation |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHypersensitivity, Delayed _ximmunology |
| 650 | 0 | 4 | _aImmunity, Cellular |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-1 _xphysiology |
| 650 | 0 | 4 |
_aLeishmania donovani _ximmunology |
| 650 | 0 | 4 |
_aLeishmaniasis, Visceral _ximmunology |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aMacrophages _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aMonocytes _ximmunology |
| 650 | 0 | 4 |
_aSpleen _xcytology |
| 700 | 1 | _aBandyopadhyay, D | |
| 700 | 1 | _aRoy, S | |
| 773 | 0 |
_tScandinavian journal of immunology _gvol. 42 _gno. 5 _gp. 540-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-3083.1995.tb03693.x _zAvailable from publisher's website |
| 999 |
_c7481030 _d7481030 |
||